Znanstveni rad - Izvorni znanstveni rad
The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence
Medicine, 101 (2022), 39; e30566. https://doi.org/10.1097/MD.0000000000030566

Prejac, Juraj; Tomek Hamzić, Dora; Librenjak, Nikša; Goršić, Irma; Kekez, Domina; Pleština, Stjepko

Citirajte ovaj rad

Prejac, J., Tomek Hamzić, D., Librenjak, N., Goršić, I., Kekez, D. i Pleština, S. (2022). The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence. Medicine, 101. (39). doi: 10.1097/MD.0000000000030566

Prejac, Juraj, et al. "The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence." Medicine, vol. 101, br. 39, 2022. https://doi.org/10.1097/MD.0000000000030566

Prejac, Juraj, Dora Tomek Hamzić, Nikša Librenjak, Irma Goršić, Domina Kekez i Stjepko Pleština. "The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence." Medicine 101, br. 39 (2022). https://doi.org/10.1097/MD.0000000000030566

Prejac, J., et al. (2022) 'The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence', Medicine, 101(39). doi: 10.1097/MD.0000000000030566

Prejac J, Tomek Hamzić D, Librenjak N, Goršić I, Kekez D, Pleština S. The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence. Medicine [Internet]. 30.09.2022. [pristupljeno 14.07.2024.];101(39). doi: 10.1097/MD.0000000000030566

J. Prejac, D. Tomek Hamzić, N. Librenjak, I. Goršić, D. Kekez i S. Pleština, "The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence", Medicine, vol. 101, br. 39, Rujan 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:002851. [Citirano: 14.07.2024.]